However, overexpression of CENPA in MAP30-treated cells could significantly rescue the down-regulation of cell proliferation and migration and the enhancement of cell senescence caused by MAP30 treatment, indicating that CENPA mediated the inhibitory effect of MAP30 treatment on bladder cancer cells. The gene discussed is CENPA; the disease is urinary bladder carcinoma.